VE-BASKET, a Simon 2-stage adaptive design, phase II, histology-independent study in nonmelanoma solid tumors harboring BRAF V600 mutations (V600m): Activity of vemurafenib (VEM) with or without cetuximab (CTX) in colorectal cancer (CRC).
Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Vall d'Hebron Hospital Universitari, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Memorial Sloan Kettering Cancer Center, Centre Léon Bérard, Royal Marsden NHS Foundation Trust, Massachusetts General Hospital, Centrum für Integrierte Onkologie, F. Hoffmann-La Roche AG, Hospital Universitario HM Sanchinarro
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2600831328